1. Home
  2. USBC vs CCCC Comparison

USBC vs CCCC Comparison

Compare USBC & CCCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

USBC

USBC Inc.

HOLD

Current Price

$0.36

Market Cap

221.2M

Sector

N/A

ML Signal

HOLD

Logo C4 Therapeutics Inc.

CCCC

C4 Therapeutics Inc.

HOLD

Current Price

$2.71

Market Cap

185.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
USBC
CCCC
Founded
N/A
2015
Country
United States
Employees
24
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
221.2M
185.1M
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
USBC
CCCC
Price
$0.36
$2.71
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
$11.80
AVG Volume (30 Days)
435.9K
1.5M
Earning Date
N/A
05-25-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
16.45
EPS
N/A
N/A
Revenue
N/A
$35,947,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
1.02
52 Week Low
$0.38
$1.09
52 Week High
$1.97
$3.64

Technical Indicators

Market Signals
Indicator
USBC
CCCC
Relative Strength Index (RSI) 32.41 72.18
Support Level N/A $2.26
Resistance Level $0.53 $2.85
Average True Range (ATR) 0.04 0.20
MACD 0.00 0.11
Stochastic Oscillator 4.84 78.26

Price Performance

Historical Comparison
USBC
CCCC

About USBC USBC Inc.

USBC Inc is a multi-disciplinary technology company that is an innovator in digital financial technologies. The company develops financial services including digital assets and banking solutions, as well as non-invasive health monitoring research. USBC has implemented a Bitcoin treasury strategy to support development and research across its various divisions. A key focus is the further development of its tokenized deposit program, a tokenized representation of a U.S.-dollar-denominated bank deposit account that operates on blockchain technology and is embedded with digital identity, alongside its legacy non-invasive sensor technology business, with the objective of creating long-term shareholder value in an evolving financial landscape.

About CCCC C4 Therapeutics Inc.

C4 Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to delivering on the promise of targeted protein degradation science to create a new generation of medicines that transforms patients' lives. The Company is progressing targeted oncology programs through clinical studies and leveraging its TORPEDO platform to efficiently design and optimize small-molecule medicines to address difficult-to-treat diseases. Its degrader medicines are designed to harness the body's natural protein recycling system to rapidly degrade disease-causing proteins, offering the potential to overcome drug resistance, and drug undruggable targets and improve patient outcomes. Its pipeline is Cemsidomide, CFT1946, and CFT8919.

Share on Social Networks: